Differentiation Induced by Achyrocline satureioides (Lam) Infusion in PC12 Cells

被引:16
作者
Blasina, M. F. [1 ]
Vaamonde, L. [1 ]
Morquio, A. [1 ]
Echeverry, C. [1 ]
Arredondo, F. [1 ]
Dajas, F. [1 ]
机构
[1] Inst Invest Biol Clemente Estable, Dept Neurochem, Montevideo 11600, Uruguay
关键词
flavonoids; quercetin; luteolin; Achyrocline satureioides (Asteraceae); differentiation; PC12; NERVE GROWTH-FACTOR; DIETARY FLAVONOIDS; OXIDATIVE STRESS; DISEASE; NEUROPROTECTION; MECHANISMS; ANTIOXIDANTS; PARKINSONS; INDUCTION; CANCER;
D O I
10.1002/ptr.2607
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Epidemiological studies have shown that flavonoid-rich plants induce beneficial health effects that are likely beyond their potent antioxidant capacity. Thus, the mechanisms by which Achyrocline satureioides (AS), a popular South American medicinal plant, protects cells and neurons in culture, are still unclear. In this sense, a recently described trophic capacity for flavonoids, similar to that evoked by growth factors, could be one of the mechanisms involved in AS cellular protection. Since this trophic activity causes differentiation of PC12 cells, the cell differentiation capacity of AS and some of its flavonoids were evaluated. PC12 cells were treated with AS infusion (10 or 20 mu g/mL of total polyphenols), quercetin (Q) (12.5 or 25 mu M), luteolin (L) (25 mu M), Q + L (12.5 mu m each one) or nerve growth factor (NGF) for 3 days. Four morphological parameters (percentage of cells with neurites longer than one cell body diameter, percentage of cells with neurites, average number of neurites per cell and percentage of fusiform cells) were explored. The AS infusion showed differentiation capacity on all parameters with similar potency when compared with NGF. Besides, AS was more potent than some of its constituent flavonoids: Q, L or their combination. Copyright (c) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:1263 / 1269
页数:7
相关论文
共 33 条
  • [1] Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
    Alexi, T
    Borlongan, CV
    Faull, RLM
    Williams, CE
    Clark, RG
    Gluckman, PD
    Hughes, PE
    [J]. PROGRESS IN NEUROBIOLOGY, 2000, 60 (05) : 409 - 470
  • [2] From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens
    Amantea, D
    Russo, R
    Bagetta, G
    Corasaniti, MT
    [J]. PHARMACOLOGICAL RESEARCH, 2005, 52 (02) : 119 - 132
  • [3] Cytoprotection by Achyrocline satureioides (Lam) DC and some of its main flavonoids against oxidative stress
    Arredondo, MF
    Blasina, F
    Echeverry, C
    Morquio, A
    Ferreira, M
    Abin-Carriquiry, JA
    Lafon, L
    Dajas, F
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2004, 91 (01) : 13 - 20
  • [4] Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases
    Auddy, B
    Ferreira, M
    Blasina, F
    Lafon, L
    Arredondo, F
    Dajas, F
    Tripathi, PC
    Seal, T
    Mukherjee, B
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2003, 84 (2-3) : 131 - 138
  • [5] Behl C, 2005, SUB CELL BIOCHEM, V38, P65
  • [6] p75 neurotrophin receptor is required for constitutive and NGF-induced survival signalling in PC12 cells and rat hippocampal neurones
    Bui, NT
    König, HG
    Culmsee, C
    Bauerbach, E
    Poppe, M
    Krieglstein, J
    Prehn, JHM
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 81 (03) : 594 - 605
  • [7] Achyrofuran, a new antihyperglycemic dibenzofuran from the South American medicinal plant Achyrocline satureioides
    Carney, JR
    Krenisky, JM
    Williamson, RT
    Luo, J
    [J]. JOURNAL OF NATURAL PRODUCTS, 2002, 65 (02): : 203 - 205
  • [8] Neuroprotection by flavonoids
    Dajas, F
    Rivera-Megret, F
    Blasina, F
    Arredondo, F
    Abin-Carriquiry, JA
    Costa, G
    Echeverry, C
    Lafon, L
    Heizen, H
    Ferreira, M
    Morquio, A
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2003, 36 (12) : 1613 - 1620
  • [9] LC determination of flavonoids:: separation of quercetin, luteolin and 3-O-methylquercetin in Achyrocline satureioides preparations
    De Souza, KCB
    Schapoval, EES
    Bassani, VL
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (3-4) : 771 - 777
  • [10] DENIZOT F, 1986, J IMMUNOL METHODS, V89, P277